on sulfonylurea
therapy alone. Excellent glycaemic control was maintained for patients for whom we had paired data
There have been great advances in the
therapy of cancer and leukemia. However, there are still many
investigations and clinical
trials employed enhanced MSCs-dependent
therapies in treatment of inflammatory
CEREBELLAR ATAXIA AS A
FIRST MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
. To create the xenograft model, human ovarian cancer cells (SKOV-3
line) were subcutaneously implanted
therapies, in improving the efficiency of immunotherapeutic tools, and in the personification